SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

$DOG.X (Dog, built on Bitcoin via Runes) is trending as the community rallies around its fair launch and potential to be a leading meme coin on the Bitcoin blockchain. Discussions highlight its strong community, the increasing number of holders, and its Bitcoin-native design, contrasting it with meme coins on other chains. Some community members believe it has the potential to surpass Dogecoin.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is trending amid speculation of a potential $15 billion licensing deal with AstraZeneca, fueling optimism around its lung cancer drug ivonescimab. Community members are actively discussing the potential deal's impact and the possibility of a short squeeze, while analysts highlight the drug's potential to challenge Keytruda in the broader oncology market.

ProShares Trust - ProShares Short Dow30 -1x Shares

ProShares Short Dow30

ProShares Short Dow30 ($DOG) is trending as community members highlight its potential as the 'meme face of Bitcoin'. Many view $DOG as more than just a memecoin, emphasizing its fair launch, community ownership, and listing on major crypto exchanges. The 'cult-like army' backing the coin and its potential to mirror $SHIB's success on ETH are also driving interest.

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

$BROKE.X is trending amid community excitement around staking application launch and ongoing buy contests. The community buzzes about the coin's strong performance relative to $SOL.X and anticipates further burns as watcher numbers climb. Enthusiastic community members highlight the project's doxxed developers and active engagement.

Wayfinder

Wayfinder (PROMPT.X) is surging in popularity, with community members actively discussing potential breakouts and price targets. Bullish sentiment is fueled by anticipation of a 'next leg up,' with some suggesting accumulation on dips. Concerns exist around short positions and whether a true reversal is underway.

Gyrodyne LLC engages in the management of a portfolio of medical office and industrial properties. Its properties include Flowerfield, Port Jefferson Professional Park, Courtland Medical Center, and Grove. The company was founded by Peter James Papadakos in 1946 and is headquartered in St. James, NY.

Gyrodyne LLC

GYRO is trending due to positive news regarding a land sale, potentially boosting its NAV, which has captured the attention of investors looking for undervalued assets. Community discussions revolve around its low float and the possibility of a significant price surge, with some comparing it to other recent low-float runners. The stock's historical volatility and upcoming shareholder meeting add to the speculative interest.

Concordium is a public, permissionless Layer 1 blockchain designed for businesses that require regulatory compliance without sacrificing privacy. Concordium was among the first to mandate identity verification at the blockchain consensus level while integrating zero-knowledge proofs (ZKPs) for selective disclosure. Launched in 2018, it embeds encrypted identity into every transaction at the protocol level, enabling accountability while preserving user confidentiality.  The project is backed by industry leaders from Volvo, IKEA, and Credit Suisse, among others, and aims to make blockchain adoption seamless for enterprises. Concordium has secured €52M in funding and partnered with Geely, a global automaker and co-owner of Volvo Cars, Volvo AB, and Daimler.  The newly appointed CEO and Executive Management team have revealed a focused strategic direction to double down on enabling stablecoin issuers, financial institutions, and payment providers to accelerate real-world adoption. With stablecoin settlement volumes projected to reach $300 billion per day by 2025, Concordium delivers a blockchain infrastructure uniquely suited for secure, programmable money solutions.

Concordium

Concordium ($CCD.X) is trending as users discuss its potential, particularly its focus on PayFi and stablecoins. Some community members are pointing to a new turnaround team and potential exchange listings as catalysts, while others highlight partnerships and the project's technology as reasons for optimism. There's a general sentiment that $CCD.X is undervalued and poised for growth.

CLV is a one-stop infrastructure platform for cross-chain and decentralized applications. The CLV chain is a Substrate-based specialized Layer-1 chain that is EVM compatible, cross-chain interoperable, and also functions as a Parachain in the Polkadot ecosystem. CLV wallet is a cross-chain all-in-one wallet, for Day-to-Day, DeFi, Metaverse and Gaming purposes. With multi-dimensional products lineup, including CLV Multi-Chain Wallets, CLV dApp Interaction Protocol, CLV Chain EVM and Universal Cross-Chain Support, CLV uniquely positioned itself as “Passport to the Omniverse.”

Clover 

Clover (CLV.X) is trending as the community anticipates a potential breakout, fueled by observations of consolidation patterns and historical cycles. Many believe a pump is imminent, drawing comparisons to previous rallies and highlighting the token's 'primed' state. However, some traders caution about potential scams and pump-and-dump schemes.

This platform is engineered to unlock the full potential of Real-World Assets (RWAs) by bringing them onto the XRP Ledger with unparalleled efficiency. Our purpose is to democratize access to high-value assets by providing a streamlined, end-to-end solution for tokenization. Functionally, we offer tools for asset verification, compliant legal wrapping, and the minting of RWA tokens. The project's core utility is twofold: for asset owners, it unlocks immediate liquidity and access to global capital markets; for investors, it offers fractional, transparent, and liquid access to investment classes like private equity and infrastructure bonds. We leverage the XRPL's native speed and built-in DEX to ensure low-cost transactions and instant settlement, setting a new standard for RWA interoperability and finance.

VOLT

VOLT ($XVM.X) is trending as community members discuss its potential for integrating with real-world assets (RWA) and its possible integration with XRP. Recent price dips are being viewed as buying opportunities, with many expressing excitement about the project's future and accessibility through Phantom Wallet. The conversation highlights early-stage excitement and speculation about significant future gains.

Lindblad Expeditions Holdings, Inc. engages in the provision of expedition cruising and travel services. It operates through the Lindblad and Natural Habitat segments. The Lindblad segment primarily includes sea-based expeditions. The Natural Habitat segment offers land-based, eco-conscious expeditions. The company was founded by Sven-Olof Lindblad on August 9, 2010 and is headquartered in New York, NY.

Lindblad Expeditions Holdings Inc

Lindblad Expeditions ($LIND) is trending amid discussions about insider trading and analyst ratings. The company is preparing to report earnings, with community members debating future prospects and management effectiveness. Recent news includes price target adjustments and upcoming earnings release, influencing investor sentiment.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CHARM Therapeutics Announces Foundation of Scientific Advisory Board (SAB)

PRESS RELEASE CHARM Therapeutics Announces Foundation of Scientific Advisory Board (SAB) LONDON 19 March 2024 -- CHARM Therapeutics ( CHARM , The Company ), a 3D deep-learning research company...

Reviewing Bavarian Nordic A/S (OTCMKTS:BVNRY) & Icosavax (NASDAQ:ICVX)

Bavarian Nordic A/S (OTCMKTS:BVNRY  Get Free Report) and Icosavax (NASDAQ:ICVX  Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare...

SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates ICVX, PGTI, IONM

SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates ICVX, PGTI, IONM SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates ICVX, PGTI, IONM PR Newswire NEW YORK, Feb. 12, 2024 NEW YORK, Feb. 12, 2024...

INVESTIGATION ALERT: Halper Sadeh LLC Investigates CSTR, ICVX,  BATL

NEW YORK, Feb. 02, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...

Icosavax (ICVX, $15.21) Aroon Indicator entered a Downtrend on February 01, 2024.

For the last three days, A.I.dvisor has detected that ICVX's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...

Kuehn Law Encourages ICVX, CSTR, AVRO, and CALB Investors to Contact Law Firm

Kuehn Law Encourages ICVX, CSTR, AVRO, and CALB Investors to Contact Law Firm Kuehn Law Encourages ICVX, CSTR, AVRO, and CALB Investors to Contact Law Firm PR Newswire NEW YORK, Feb. 1, 2024 NEW...

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates CSTR, EGLE, ICVX

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates CSTR, EGLE, ICVX SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates CSTR, EGLE, ICVX PR Newswire NEW YORK, Jan. 29, 2024 NEW YORK, Jan. 29, 2024...

Icosavax (ICVX, $15.2) Aroon Indicator entered a Downtrend on January 23, 2024.

Kuehn Law Encourages HA, ICVX, PXD, and HARP Investors to Contact Law Firm

NEW YORK, Jan. 19, 2024 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek...

Icosavax (NASDAQ:ICVX) Sees Large Volume Increase

Icosavax, Inc. (NASDAQ:ICVX  Get Free Report) saw strong trading volume on Friday . 382,110 shares changed hands during trading, a decline of 46% from the previous sessions volume of...

Icosavax is a biopharmaceutical company leveraging its innovative virus-like particle (VLP) platform technology to develop vaccines against infectious diseases, with an initial focus on life-threatening respiratory diseases. Icosavaxâ??s VLP platform technology is designed to enable multivalent, particle-based display of complex viral antigens, which it believes will induce broad, robust, and durable protection against the specific viruses targeted. Icosavaxâ??s pipeline includes vaccine candidates targeting respiratory syncytial virus (RSV), human metapneumovirus (hMPV), and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Icosavax was formed in 2017 to advance the breakthrough VLP technology from the Institute for Protein Design at the University of Washington with the goal to discover, develop, and commercialize vaccines against infectious diseases.

Current Price	$15.31
Prev Close	$15.45
Open	$15.40
Dividend Yield	N/A
50-Day Moving Average	$15.45
Beta	0.00
Avg. Volume	942,521.76
PE Ratio	-6.89

52-Week High	$16.11
52-Week Low	$4.75
Market Capitalization	$766.86M
EPS (Annual)	-$2.22
Price to Book	3.30
Revenue Per Employee	N/A
Enterprise Value/EBITDA	-1.63

ICVX
Icosavax Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ICVX News

ICVX Icosavax Inc